首页> 外文期刊>Medicine. >TCM nonpharmacological interventions for ankylosing spondylitis
【24h】

TCM nonpharmacological interventions for ankylosing spondylitis

机译:强直性脊柱炎的TCM非药物干预措施

获取原文
获取外文期刊封面目录资料

摘要

Background: Ankylosing spondylitis (AS) is a common infammatory rheumatic disease that affects the axial skeleton. Traditional Chinese medicine (TCM) nonpharmacological interventions are gaining an increasing popularity for AS. Nevertheless, the evidence of efficacy and safety of random controlled trials (RCTs) remains controversial. This study aims to evaluate the efficacy and acceptability of different TCM nonpharmacological therapies by systematic review and network meta-analysis. Methods: According to the strategy, the authors will retrieve a total of 7 electronic databases by December 2020, including PubMed, the Cochrane Library, EMbase, China National Knowledge Infrastructure, China Biological Medicine, Chongqing VIP, and Wan-fang databases After a series of screening, 2 researchers will use Aggregate Data Drug Information System and Stata software to analyze the data extracted from the randomized controlled trials of TCM nonpharmacological interventions for AS. The primary outcome will be the improvement of Pain intensity and functional status/disability and the secondary outcomes will include lobal improvement, health-related quality of life, satisfaction with treatment, and adverse events. Both classical meta-analysis and network meta-analysis will be implemented to investigate direct and indirect evidences on this topic. The quality of the evidence will be evaluated using the Grading of Recommendations Assessment, Development and Evaluation instrument. Results: This study will provide a reliable evidence for the selection of TCM nonpharmacological therapies in the treatment of AS. Conclusion: This study will generate evidence for different TCM nonpharmacological therapies for AS and provide a decisionmaking reference for clinical research. Ethics and dissemination: This study does not require ethical approval. The results will be disseminated through a peerreviewed publication. OSF registration number: DOI 10.17605/OSF.IO/FHD2U Abbreviations: ADDIS = Aggregate Data Drug Information System, AS = ankylosing spondylitis, GRADE = Grading of Recommendations Assessment, Development, and Evaluation, NMA = network meta-analysis, PSRF = potential scale-reduced factor, RCTs = randomized controlled trials, TCM = Traditional Chinese medicine.
机译:背景:强直性脊柱炎(AS)是一种影响轴向骨架的常见症状风湿性疾病。中药(TCM)非药物干预措施正在增加越来越受欢迎。然而,随机对照试验的有效性和安全性的证据仍然存在争议。本研究旨在通过系统审查和网络荟萃分析评估不同TCM非武装疗法的功效和可接受性。方法:根据该策略,作者将在2020年12月20日,包括PubMed,Cochrane图书馆,EMBASE,中国国家知识基础设施,中国生物医学,重庆VIP和WAN-Fang数据库后,共有7个电子数据库。筛查,2名研究人员将使用总数据药物信息系统和Stata软件分析从TCM非药物干预的随机对照试验中提取的数据。主要结果将改善疼痛强度和功能状态/残疾,二次结果将包括叶片改善,与卫生相关的生活质量,治疗的满意度以及治疗的满意度和不良事件。将实施古典元分析和网络元分析,以调查本主题的直接和间接证据。将使用建议评估,开发和评估文书的评分进行评估证据的质量。结果:本研究将提供可靠的证据,以选择TCM非物理治疗疗法。结论:本研究将为临床研究提供不同的中医非武装疗法的证据。道德和传播:本研究不需要道德批准。结果将通过PEERREVIED出版物传播。 OSF注册号:DOI 10.17605 / OSF.IO / FHD2U缩写:ADDIS =骨料数据药物信息系统,AS =强直性脊柱炎,等级=建议评估评估,开发和评估,NMA =网络元分析,PSRF =潜在量表 - RCT =随机对照试验,中医=中药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号